BRVE insider buying
6 cluster buysBraveheart Bio, Inc.
When two or more insiders at Braveheart Bio, Inc. buy BRVE in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in BRVE plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Aug 7 – Aug 7, 2026Detected Aug 11, 2026Executive buyer10 insidersTotal bought$159.0MMarket capUnknown
- Aug 7 – Aug 7, 2026Detected Aug 11, 2026Executive buyer9 insidersTotal bought$139.2MMarket capUnknown
- Aug 7 – Aug 7, 2026Detected Aug 11, 2026Executive buyer8 insidersTotal bought$104.3MMarket capUnknown
3 more clusters in BRVE
Choose Basic for full history, or Pro for email and Telegram alerts after new insider clusters are detected. Both plans start with a 7-day trial.
All notable open-market buys in BRVE
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 7, 2026 | 10% Owner | 1,920,000 | $18.00 | $34.6M | SEC ↗ |
| Aug 7, 2026 | 10% Owner | 1,680,000 | $18.00 | $30.2M | SEC ↗ |
| Aug 7, 2026 | Chimovits Erezcluster Director, 10% Owner | 1,666,667 | $18.00 | $30.0M | SEC ↗ |
| Aug 7, 2026 | ORBIMED ADVISORS LLCcluster Director, 10% Owner | 1,666,667 | $18.00 | $30.0M | SEC ↗ |
| Aug 7, 2026 | AH Bio Fund IV, L.P.cluster 10% Owner | 1,100,000 | $18.00 | $19.8M | SEC ↗ |
| Aug 7, 2026 | Chimovits Erezcluster Director, 10% Owner | 273,333 | $18.00 | $4.9M | SEC ↗ |
| Aug 7, 2026 | ORBIMED ADVISORS LLCcluster Director, 10% Owner | 273,333 | $18.00 | $4.9M | SEC ↗ |
| Aug 7, 2026 | Viehbacher Christophercluster Director | 83,333 | $18.00 | $1.5M | SEC ↗ |
| Aug 7, 2026 | Murdoch Traviscluster Director, CEO and President | 83,333 | $18.00 | $1.5M | SEC ↗ |
| Aug 7, 2026 | Lubner David Charlescluster Director | 55,555 | $18.00 | $1.0M | SEC ↗ |
| Aug 7, 2026 | Rickey James Paulcluster Chief Financial Officer | 27,777 | $18.00 | $500.0K | SEC ↗ |
| Aug 7, 2026 | Malek David Icluster Director | 4,166 | $18.00 | $75.0K | SEC ↗ |
| Aug 7, 2026 | Anderson Michele A.cluster Chief Development Officer | 1,111 | $18.00 | $20.0K | SEC ↗ |
BRVE insider buying — FAQ
- Are insiders buying BRVE stock?
- Yes — 10 distinct insiders have bought BRVE (Braveheart Bio, Inc.) on the open market, including 6 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Aug 11, 2026.
- How much BRVE stock have insiders bought?
- Insiders have bought a combined $159.0M of BRVE across 13 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in BRVE?
- A cluster buy is two or more distinct Braveheart Bio, Inc. insiders — officers, directors, or 10% owners — each buying BRVE on the open market within a rolling window. BRVE has 6 detected cluster buys to date.
- Where does this BRVE insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in BRVE
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy BRVE within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding BRVE.